GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
10 juin 2024 08h30 HE
|
GeneDx Holdings Corp.
-- New integration to streamline access for health systems and improve provider and patient journeys using Epic for electronic connections -- -- Increases commercial footprint and focus on...
GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients
05 juin 2024 07h00 HE
|
GeneDx Holdings Corp.
STAMFORD, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the first-of-its-kind patient...
GeneDx to Participate in Upcoming Investor Conferences
22 mai 2024 16h05 HE
|
GeneDx Holdings Corp.
GeneDx (Nasdaq: WGS) today announced that company management will participate in two upcoming investor conferences in June.
GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
29 avr. 2024 16h05 HE
|
GeneDx Holdings Corp.
GeneDx Holdings Corp. (Nasdaq: WGS) today reported its financial results for the first quarter of 2024.
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
23 avr. 2024 08h30 HE
|
GeneDx Holdings Corp.
STAMFORD, Conn., April 23, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a strategic partnership with...
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
04 avr. 2024 16h05 HE
|
GeneDx Holdings Corp.
Management will host a conference call on Monday, April 29, 2024 to discuss first quarter 2024 financial and operating results at 4:30 p.m. Eastern Time.
GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics
14 mars 2024 08h30 HE
|
GeneDx Holdings Corp.
STAMFORD, Conn., March 14, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced its scientific contributions at...
GeneDx to Participate in 44th Annual Cowen Health Care Conference
26 févr. 2024 16h05 HE
|
GeneDx Holdings Corp.
GeneDx (Nasdaq: WGS) today announced that company management will participate in the Cowen Healthcare Conference from March 4-6 in Boston, MA.
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
20 févr. 2024 16h26 HE
|
GeneDx Holdings Corp.
GeneDx Holdings Corp. (Nasdaq: WGS) reported its financial results for the fourth quarter and full year of 2023.
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024
01 févr. 2024 16h30 HE
|
GeneDx Holdings Corp.
GeneDx management will host a conference call at 4:30 p.m. Eastern Time on February 20, 2024 to discuss 2023 results and share full year 2024 guidance.